Parkside Financial Bank & Trust’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-470
Closed -$3.46K 2061
2023
Q2
$3.46K Buy
+470
New +$4.36K ﹤0.01% 1500
2022
Q4
Sell
-214
Closed -$4K 2019
2022
Q3
$4K Buy
214
+86
+67% +$2.39K ﹤0.01% 1289
2022
Q2
$4K Sell
128
-31
-19% -$1.06K ﹤0.01% 1315
2022
Q1
$7K Sell
159
-38
-19% -$1.68K ﹤0.01% 1148
2021
Q4
$9K Buy
+197
New +$8.91K ﹤0.01% 1057
2020
Q3
Sell
-76
Closed -$6K 1547
2020
Q2
$6K Sell
76
-3
-4% -$224 ﹤0.01% 890
2020
Q1
$5K Buy
79
+18
+30% +$1.04K ﹤0.01% 870
2019
Q4
$3K Hold
61
﹤0.01% 1044
2019
Q3
$3K Buy
61
+11
+22% +$512 ﹤0.01% 1049
2019
Q2
$2K Buy
50
+24
+92% +$1.15K ﹤0.01% 1157
2019
Q1
$1K Sell
26
-5
-16% -$295 ﹤0.01% 1313
2018
Q4
$1K Buy
31
+8
+35% +$516 ﹤0.01% 1194
2018
Q3
$2K Hold
23
﹤0.01% 1069
2018
Q2
$1K Hold
23
﹤0.01% 1217
2018
Q1
$1K Hold
23
﹤0.01% 1162
2017
Q4
$1K Hold
23
﹤0.01% 1111
2017
Q3
$1K Hold
23
﹤0.01% 1109
2017
Q2
$1K Hold
23
﹤0.01% 1114
2017
Q1
$1K Buy
23
+2
+10% +$61 ﹤0.01% 1090
2016
Q4
$1K Buy
+21
New +$630 ﹤0.01% 1079

Other funds holding EBS

Parkside Financial Bank & Trust's EBS Position: Q3 2023 in Review

Parkside Financial Bank & Trust sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 470 shares — an estimated $3.46K sold.

Parkside Financial Bank & Trust first reported a position in EBS in Q4 2016 and held it in 20 quarters. The position peaked at $9K in Q4 2021. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

  • Parkside Financial Bank & Trust reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 470 Emergent Biosolutions shares in Q3 2023, an estimated $3.46K.
  • Parkside Financial Bank & Trust first reported a position in Emergent Biosolutions in Q4 2016 and held it in 20 quarters.
  • Parkside Financial Bank & Trust's Emergent Biosolutions position peaked at $9K in Q4 2021.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2023, filed 13 Nov 2023.